BioSpace News Archive

Biotech and pharma companies strengthen their leadership teams and committees with new appointments.

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, announced that half of the patients have been enrolled and started the treatment in the company’s Phase II-study with the company’s product candidate LL-37 for treatment of venous leg ulcers.

Polyphor AG announced that it will provide an overview on its Outer Membrane Protein Targeting Antibiotics programs at the American Society of Microbiology Microbe 2019 Conference taking place in San Francisco, California, from June 20 to 24, 2019.

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results as of and for the year ended December 31, 2018 as well as operative highlights.

Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs

Researchers at Cornell University have created a system of circulating liquid — “robot blood” — within robotic structures, to store energy and power robotic applications for sophisticated, long-duration tasks.

Spero Therapeutics, Inc. announced that it entered into a collaboration with the Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis, an indication that is designated as a critical concern by the World Health Organization.

Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce new data from studies recently conducted with its antimicrobial product BTX 1801.

Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office for: “Remote Monitoring and Dynamic Document Management Systems and Methods.”

endpoint Clinical, the leading global interactive response technology company, and Cmed Technology, the technology division of a full-service CRO with its encapsia clinical data suite, announced today a new interoperability in their clinical trial software systems.